Literature DB >> 4962164

Studies on the site of biosynthesis of acidic glycoproteins of guinea-pig serum.

J L Simkin, J C Jamieson.   

Abstract

1. Studies were carried out to determine the cellular and subcellular site of biosynthesis of components of fraction I, an alpha-globulin fraction containing acidic glycoproteins isolated from guinea-pig serum. l-[U-(14)C]Leucine or -valine and d-[1-(14)C]glucosamine were used as precursors. 2. A lag of about 10min. occurred before appreciable label appeared in fraction I of serum after injection of leucine or glucosamine. Label in fraction I after 60min. labelling with glucosamine was present almost entirely in hexosamine and sialic acid. 3. Site of synthesis was investigated by studies in vivo up to 17min. after injection of precursor. Particulate subcellular fractions isolated from liver, spleen and kidney or homogenates of the latter two tissues were extracted with Lubrol. Extracts were allowed to react by double diffusion with antisera to fraction I or to subfractions isolated from it, and gels were subsequently subjected to radioautography. With either amino acid or glucosamine as precursor, only extracts of the microsome fraction of liver formed precipitin lines that were appreciably radioactive. 4. The role of the microsome fraction of liver in the synthesis of these glycoproteins was confirmed by immunological studies after incubation of liver slices with leucine or glucosamine. Incorporation of leucine was also investigated in a cell-free microsome system. 5. Material was also precipitated from certain Lubrol extracts of liver microsomes by direct addition of antiserum and its radioactivity measured. Degradation of material thus precipitated and use of heterologous immune systems showed that labelling of precipitin lines represented biosynthesis. 6. A study of extraction procedures suggested that the substances present in the microsome fraction of liver that react with specific antisera are associated with membranous structures. 7. Most or all precipitin lines formed by Lubrol extracts of liver microsomes interacted with precipitin lines given by guinea-pig serum or fraction I, immunological identity being apparent with some lines. The microsome-bound substances thus represent serum glycoproteins or precursors of them. 8. The distribution of label in various tissues and in the protein of subcellular fractions of liver after administration of [(14)C]glucosamine to the guinea pig was also studied. Some variation in results obtained with liver was found depending on the fractionation medium used.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4962164      PMCID: PMC1270379          DOI: 10.1042/bj1030153

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  [RESISTANCE OF THE BIOSYNTHESIS OF HEMOGLOBIN IN HEN RETICULOCYTES TO ROENTGEN IRRADIATION].

Authors:  H SCHALL; F TURBA
Journal:  Biochem Z       Date:  1963-12-03

2.  SOME IMMUNOCHEMICAL STUDIES ON OROSOMUCOID.

Authors:  S A BARKER; P H WHITEHEAD
Journal:  Clin Chim Acta       Date:  1963-11       Impact factor: 3.786

3.  THE BIOSYNTHESIS OF GLYCOPROTEINS. 3. GLUCOSAMINE INTERMEDIATES IN PLASMA GLYCOPROTEIN SYNTHESIS IN LIVERS OF PUROMYCIN-TREATED RATS.

Authors:  J MOLNAR; G B ROBINSON; R J WINZLER
Journal:  J Biol Chem       Date:  1964-10       Impact factor: 5.157

4.  THE SUBECELLULAR SITE OF HEXOSAMINE INCORPORATION INTO LIVER PROTEIN.

Authors:  E J SARCIONE; M BOHNE; M LEAHY
Journal:  Biochemistry       Date:  1964-12       Impact factor: 3.162

5.  Comparative antigenicity of native and "desialized" orosomucoid in rabbits.

Authors:  E ATHINEOS; M THORNTON; R J WINZLER
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

6.  The cleavage of human alpha1-acid glycoprotein by pepsin.

Authors:  H WEINFELD; M TUNIS
Journal:  J Biol Chem       Date:  1960-06       Impact factor: 5.157

7.  The biosynthesis of rat serum albumin. II. Intracellular phenomena in the secretion of newly formed albumin.

Authors:  T PETERS
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

8.  Glycoprotein biosynthesis: studies on thyroglobulin. Characterization of a particulate precursor and radioisotope incorporation by thyroid slices and particle systems.

Authors:  R G Spiro; M J Spiro
Journal:  J Biol Chem       Date:  1966-03-25       Impact factor: 5.157

9.  [Elaboration of glycoproteins in the Golgi apparatus of the liver cells in rats; radioautographic study by electron microscopy after injection of galactose-3H].

Authors:  B Droz
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1966-04-18

10.  Transfer of N-acetylneuraminic acid to incomplete glycoproteins associated with microsomes.

Authors:  P J O'Brien; M R Canady; C W Hall; E F Neufeld
Journal:  Biochim Biophys Acta       Date:  1966-04-25
View more
  5 in total

1.  Studies on the nature of microsome-bound substances involved in the biosynthesis of acidic glycoproteins of guinea-pig serum.

Authors:  J L Simkin; J C Jamieson
Journal:  Biochem J       Date:  1968-01       Impact factor: 3.857

2.  Glycosylation in vitro of an asparagine sequon catalysed by preparations of yeast cell membranes.

Authors:  Z Khalkhali; R D Marshall; F Reuvers; C Habets-Willems; P Boer
Journal:  Biochem J       Date:  1976-10-15       Impact factor: 3.857

3.  Studies on the effect of lysosomotropic agents on the release of Gal beta 1-4GlcNAc alpha-2,6-sialytransferase from rat liver slices during the acute-phase response.

Authors:  G Lammers; J C Jamieson
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

4.  Electron microscopic radioautographic detection of sites of protein synthesis and migration in liver.

Authors:  C A Ashley; T Peters
Journal:  J Cell Biol       Date:  1969-11       Impact factor: 10.539

5.  Biogenesis of microsomal membrane glycoproteins in rat liver. I. Presence of glycoproteins in microsomes and cytosol.

Authors:  F Autuori; H Svensson; G Dallner
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.